Marketed as an alternative to traditional nicotine, 6-methyl nicotine is drawing growing concern from public health authorities in countries across the European Union.
Also known as Metatine, this synthetic molecule, reportedly more addictive than tobacco-derived nicotine according to some studies, has quietly made its way into vaping products in Belgium, France and Sweden.
Over recent months, this relatively new synthetic compound has sparked increasing scrutiny from European public health bodies.
